From the President: on the record

PSA is redoubling our efforts to ensure fair remuneration for pharmacists that reflects our training and expertise. The launch of Pharmacists in 2023 in...

Federal election health platforms

Last week, several pledges were made by the Coalition and the Opposition that will impact health care around the nation. The Coalition issued a statement...

‘Don’t you know who I am?’: Why patient identification is so...

When we think patient safety, pharmacists’ minds jump to drug interactions, adverse events or toxic doses. But incorrect patient identification can have equal capacity...

From the President: Valuing our most vulnerable

Pharmacists spending more time on the ground in aged care has become an urgent priority. It is often said that a measure of civilisation...

Aged care residents deserve better

Pharmacists should be embedded in aged care facilities nationwide.   The health of the aged care sector matters a great deal to PSA and the...

Bumetanide for Alzheimer’s disease

Alzheimer’s disease is the most common form of dementia, affecting up to 70% of all people with dementia.1 In the early stages, symptoms can...